Development of a Qualitative Scale to Asses the Acceptability of Percutaneous Techniques. A Delphi Study
Accept_scale
1 other identifier
observational
20
1 country
1
Brief Summary
This study aims to develop a new evaluation tool to assess patient acceptability of percutaneous interventions. A Delphi methodology will be implemented, involving the recruitment of a panel of experts in percutaneous interventions and pain management. The scale will be developed through several iterative phases until a final version is reached, comprising clearly defined domains, subdomains, items, and questions to be answered by patients in order to obtain an overall acceptability score for the percutaneous technique received. The scale is intended to be applicable across a wide range of percutaneous interventions and, consequently, to a broad patient population undergoing different percutaneous treatments depending on their clinical condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 13, 2026
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedApril 29, 2026
April 1, 2026
5 months
January 13, 2026
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Consensus among the experts
Consensus must be achieved among the experts panel to establish final decisions on the acceptability scale development.
Consensus will be achieved through 5 evaluation phases: Day 1 after first focus group Day 7 after second focus group Month 1 after first individual evaluation Month 2 after second individual evaluation Month 4 after second individual evaluation
Study Arms (1)
Experts Panel
20 experts (3 women and 17 men) took part in the study. The expert panel consisted of 14 physiotherapists, 2 psychologists, and 3 physicians
Interventions
The expert panel conducted iterative focus group sessions and successive individual evaluation phases until consensus was reached on the development of the acceptability scale.
Eligibility Criteria
Experts in percutaneous interventions and pain management
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
University of Zaragoza
Zaragoza, Zaragoza, 50009, Spain
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 13, 2026
First Posted
February 2, 2026
Study Start
April 1, 2025
Primary Completion
September 1, 2025
Study Completion (Estimated)
August 1, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Once research has been published
- Access Criteria
- Study protocol will be publish in a scientific journal.
Data will be shared on a reasonable request contacting with the main author once data has been published. Anyway, Individual participant data (IPD) will be shared with other researchers in accordance with data sharing protocols and participant consent, ensuring confidentiality and ethical considerations are maintained.